Posts by KCAS Bio
May 4
- May 5
KCAS Bio will be attending Swiss Biotech Day in Basel, on May 4-5, 2026. The Swiss Biotech Day is a global life sciences conference that brings together thousands of professionals from around the world to network, exchange ideas, and drive international collaboration across R&D, manufacturing, AI, and investment. Connect…
Blogs
The world of medicine relies heavily on innovation, and Contract Research Organizations (CROs) are key players behind the scenes. But what exactly is a CRO, and why are these organizations so crucial to the development of new therapies and medical advancements? Let’s explore what CROs do and why they’re vital…
News
In modern bioanalytical research, data quality remains the defining metric of success. At the same time, study complexity continues to increase. KCAS Bio is advancing its global flow cytometry services with a focused strategy that integrates AI-enabled efficiencies, harmonized workflows, and high-parameter technologies. The goal is…
Blogs
Some molecules refuse to be easy to study. In this case, the drug was highly charged, sticky, and extremely sensitive to proteolysis, and previous partner labs had already struggled with it; “they’ve never seen anything like this before!” Keeping the entire process, from method transfer, optimization, validation, and GLP…
webinars
Biomarkers can move a program forward fast. Or slow it down with rework. Biomarkers shape decisions from discovery through late-stage clinical trials. But the wrong assay plan can waste time, budget and samples. In this KCAS Bio roundtable, we share practical ways to align context of use, assay design and…
Blogs
At KCAS Bio, we supported a therapeutic monoclonal antibody for advanced solid tumors from non-human primate (NHP) toxicology through first-in-human (FIH) dose escalation into phase 2 expansion. This project combined receptor occupancy assays (ROA) by flow cytometry for cell-surface binding on monocytes, immunophenotyping (IPT) for activation markers, and…
News
KCAS Bio is proud to announce that its EU site (Lyon, France) has successfully renewed its Statement of Compliance with Good Laboratory Practices (GLP), confirming its ability to deliver GLP-grade bioanalytical methods in support of preclinical studies. Our GLP test facility was granted a Level of compliance “A”, reinforcing KCAS Bio’s capability to…
May 31
- June 4
KCAS Bio will be attending the 74th Conference on Mass Spectrometry and Allied Topics (ASMS) in San Diego, California from May 31 – June 4, 2026. This event is a cornerstone in the field of mass spectrometry, bringing together experts, innovators, and visionaries to share advancements and explore the future…
May 11
- May 15
KCAS Bio is exhibiting at the Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT), taking place May 11th-15th, 2026, in Boston, MA. This event serves as a global hub for scientific discovery and collaboration, bringing together leaders and innovators in the field of gene and cell…
May 11
- May 14
KCAS Bio will be exhibiting at the American Association of Pharmaceutical Scientists National Biotechnology Conference (AAPS NBC), taking place from May 11th to May 14th, 2026, in San Diego, California. Visit KCAS Bio at Booth #302 to engage with our experts, explore our cutting-edge bioanalysis solutions, and learn how we…
Posters & Papers
Discover in this white paper a global collaboration between KCAS Bio and its strategic partner, Crux Biolabs, to harmonize and validate a standardized 15-color spectral flow cytometry panel for pan-leukocyte profiling across multiple sites. If you have any questions about these services or any others offered by…
April 27
- April 28
KCAS Bio will be attending BioVaria in Munich, on April 27-28, 2026. This event connects leading tech transfer professionals and academic innovators with start-ups and representatives from the global biotech and pharma industry. Supporting Biologics Drug Development KCAS Bio supports small and large molecule drug development across preclinical and…